The Senate has scheduled a vote on an amendment sponsored by Sen. Richard Durbin, D-Ill., to the pending, must-pass Food and Drug Administration (FDA) User Fee Act, for 2 p.m. EST on Thursday, May 24. The amendment, if approved, would, among other things, set new requirements for dietary supplement facility registration and listing of all products and their ingredients with FDA.
The product registration and listing language in his amendment is identical to that contained in last year's S. 1310, also sponsored by Durbin, which AHPA strongly opposes. Click here [PDF] to review the AHPA analysis of the Durbin dietary supplement amendment.
ACTION REQUESTED: If you agree with the AHPA position and oppose this attempt by Durbin to amend the Dietary Supplement Health and Education Act, there is still time to contact your two U.S. senators and express your opposition to the Durbin amendment on dietary supplements to the FDA User Fee Act (S. 3187).
AHPA members and others in the supplements industry are invited to ask their employees and sales representatives to also call their senators. All calls should be made prior to 2 p.m. on Thursday.
You can find the contact information for your senators at www.senate.gov. Given the time sensitivity of this matter, phone calls are the quickest and most effective way to communicate your opposition to this amendment.